73
Participants
Start Date
December 31, 2007
Primary Completion Date
March 31, 2011
Study Completion Date
December 31, 2014
HyperAcute(R)-Pancreatic Cancer Vaccine
100 million vaccine cells will be injected intradermally for up to 14 vaccinations over approximately 8 months
Thomas Jefferson University, Philadelphia
University of Miami, Miami
University Hospitals Case Western, Cleveland
Indiana University, Indianapolis
University of Minnesota Cancer Center, Minneapolis
Evanston Northwestern Healthcare, Evanston
Northwestern University, Chicago
Baylor College of Medicine, Houston
University of Texas Health Science Center, San Antonio
University of Colorado, Aurora
Mayo Clinic - Scottsdale, Scottsdale
University of New Mexico, Albuquerque
University of Southern California, Los Angeles
University of California - Irvine, Orange
California Pacific Medical Center, San Francisco
Lahey Clinic, Burlington
Rhode Island Hospital, Providence
Roger Williams Medical Center, Providence
Lead Sponsor
NewLink Genetics Corporation
INDUSTRY